Virginia Democrats want to approve embryonic stem cell research, ban therapeutic cloning

NewsGuard 100/100 Score

Democrats in the Virginia General Assembly plan to propose legislation that would authorize human embryonic stem cell research in the state, Jesse Furgeson, spokesperson for state House Democratic Caucus Chair Brian Moran, said recently, the Richmond Times-Dispatch reports.

Some Republicans last year attempted to pass a measure that would have banned state funding of any institution conducting embryonic stem cell research.

Democrats plan to introduce a bill sponsored by Moran, as well as a measure sponsored by state Sens. Janet Howell (D) and Creigh Deeds (D) that would allow the state to provide funding to the Christopher Reeve Stem Cell Research Fund.

Deeds said the state Senate bill would ban the "therapeutic" cloning of embryos for stem cell research.

According to the Times-Dispatch, the legislative package also would require an oversight committee to review research projects and would require informed consent for donation of embryos.

The General Assembly cannot appropriate any funds during the current legislative session (Hostetler, Richmond Times-Dispatch, 1/6).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseases